Skip to main content
  • Submit
  • About
    • Editorial Board
    • PNAS Staff
    • FAQ
    • Accessibility Statement
    • Rights and Permissions
    • Site Map
  • Contact
  • Journal Club
  • Subscribe
    • Subscription Rates
    • Subscriptions FAQ
    • Open Access
    • Recommend PNAS to Your Librarian
  • Log in
  • My Cart

Main menu

  • Home
  • Articles
    • Current
    • Special Feature Articles - Most Recent
    • Special Features
    • Colloquia
    • Collected Articles
    • PNAS Classics
    • List of Issues
  • Front Matter
  • News
    • For the Press
    • This Week In PNAS
    • PNAS in the News
  • Podcasts
  • Authors
    • Information for Authors
    • Editorial and Journal Policies
    • Submission Procedures
    • Fees and Licenses
  • Submit
  • About
    • Editorial Board
    • PNAS Staff
    • FAQ
    • Accessibility Statement
    • Rights and Permissions
    • Site Map
  • Contact
  • Journal Club
  • Subscribe
    • Subscription Rates
    • Subscriptions FAQ
    • Open Access
    • Recommend PNAS to Your Librarian

User menu

  • Log in
  • My Cart

Search

  • Advanced search
Home
Home

Advanced Search

  • Home
  • Articles
    • Current
    • Special Feature Articles - Most Recent
    • Special Features
    • Colloquia
    • Collected Articles
    • PNAS Classics
    • List of Issues
  • Front Matter
  • News
    • For the Press
    • This Week In PNAS
    • PNAS in the News
  • Podcasts
  • Authors
    • Information for Authors
    • Editorial and Journal Policies
    • Submission Procedures
    • Fees and Licenses

New Research In

Physical Sciences

Featured Portals

  • Physics
  • Chemistry
  • Sustainability Science

Articles by Topic

  • Applied Mathematics
  • Applied Physical Sciences
  • Astronomy
  • Computer Sciences
  • Earth, Atmospheric, and Planetary Sciences
  • Engineering
  • Environmental Sciences
  • Mathematics
  • Statistics

Social Sciences

Featured Portals

  • Anthropology
  • Sustainability Science

Articles by Topic

  • Economic Sciences
  • Environmental Sciences
  • Political Sciences
  • Psychological and Cognitive Sciences
  • Social Sciences

Biological Sciences

Featured Portals

  • Sustainability Science

Articles by Topic

  • Agricultural Sciences
  • Anthropology
  • Applied Biological Sciences
  • Biochemistry
  • Biophysics and Computational Biology
  • Cell Biology
  • Developmental Biology
  • Ecology
  • Environmental Sciences
  • Evolution
  • Genetics
  • Immunology and Inflammation
  • Medical Sciences
  • Microbiology
  • Neuroscience
  • Pharmacology
  • Physiology
  • Plant Biology
  • Population Biology
  • Psychological and Cognitive Sciences
  • Sustainability Science
  • Systems Biology
Research Article

Evidence for aggregation-independent, PrPC-mediated Aβ cellular internalization

View ORCID ProfileAlejandro R. Foley, View ORCID ProfileGraham P. Roseman, Ka Chan, Amanda Smart, View ORCID ProfileThomas S. Finn, Kevin Yang, View ORCID ProfileR. Scott Lokey, View ORCID ProfileGlenn L. Millhauser, and Jevgenij A. Raskatov
PNAS November 17, 2020 117 (46) 28625-28631; first published November 2, 2020; https://doi.org/10.1073/pnas.2009238117
Alejandro R. Foley
aDepartment of Chemistry and Biochemistry, University of California, Santa Cruz, CA 95064
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Alejandro R. Foley
Graham P. Roseman
aDepartment of Chemistry and Biochemistry, University of California, Santa Cruz, CA 95064
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Graham P. Roseman
Ka Chan
aDepartment of Chemistry and Biochemistry, University of California, Santa Cruz, CA 95064
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amanda Smart
aDepartment of Chemistry and Biochemistry, University of California, Santa Cruz, CA 95064
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas S. Finn
aDepartment of Chemistry and Biochemistry, University of California, Santa Cruz, CA 95064
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Thomas S. Finn
Kevin Yang
aDepartment of Chemistry and Biochemistry, University of California, Santa Cruz, CA 95064
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R. Scott Lokey
aDepartment of Chemistry and Biochemistry, University of California, Santa Cruz, CA 95064
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for R. Scott Lokey
Glenn L. Millhauser
aDepartment of Chemistry and Biochemistry, University of California, Santa Cruz, CA 95064
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Glenn L. Millhauser
  • For correspondence: glennm@ucsc.edu jraskato@ucsc.edu
Jevgenij A. Raskatov
aDepartment of Chemistry and Biochemistry, University of California, Santa Cruz, CA 95064
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: glennm@ucsc.edu jraskato@ucsc.edu
  1. Edited by Samuel H. Gellman, University of Wisconsin–Madison, Madison, WI, and approved October 8, 2020 (received for review May 8, 2020)

  • Article
  • Figures & SI
  • Info & Metrics
  • PDF
Loading

Significance

Amyloid β (Aβ) aggregation has been the therapeutic target of several Alzheimer’s disease (AD) clinical trials. Aβ exists in many different aggregated forms, making it exceedingly challenging to target. Evidence links intracellular Aβ accumulation and AD pathogenesis. We report that amino acids 1 to 30 of Aβ, Aβ (1–30), do not aggregate yet display cellular uptake stereospecificity when compared to its mirror image, suggesting that Aβ uptake is predominantly receptor-mediated and may be independent from its aggregation state. Additionally, we found Aβ (1–30) internalization to depend on PrPC expression. Aβ (1–30) thus represents a powerful tool to study mechanisms of Aβ cellular internalization and suggests that Aβ uptake could be modulated by therapeutically targeting high-affinity Aβ receptors.

Abstract

Evidence linking amyloid beta (Aβ) cellular uptake and toxicity has burgeoned, and mechanisms underlying this association are subjects of active research. Two major, interconnected questions are whether Aβ uptake is aggregation-dependent and whether it is sequence-specific. We recently reported that the neuronal uptake of Aβ depends significantly on peptide chirality, suggesting that the process is predominantly receptor-mediated. Over the past decade, the cellular prion protein (PrPC) has emerged as an important mediator of Aβ-induced toxicity and of neuronal Aβ internalization. Here, we report that the soluble, nonfibrillizing Aβ (1–30) peptide recapitulates full-length Aβ stereoselective cellular uptake, allowing us to decouple aggregation from cellular, receptor-mediated internalization. Moreover, we found that Aβ (1–30) uptake is also dependent on PrPC expression. NMR-based molecular-level characterization identified the docking site on PrPC that underlies the stereoselective binding of Aβ (1–30). Our findings therefore identify a specific sequence within Aβ that is responsible for the recognition of the peptide by PrPC, as well as PrPC-dependent cellular uptake. Further uptake stereodifferentiation in PrPC-free cells points toward additional receptor-mediated interactions as likely contributors for Aβ cellular internalization. Taken together, our results highlight the potential of targeting cellular surface receptors to inhibit Aβ cellular uptake as an alternative route for future therapeutic development for Alzheimer’s disease.

  • Alzheimer’s disease
  • amyloid β
  • prion protein (PrP)
  • mirror-image peptides
  • receptor-mediated internalization

Footnotes

  • ↵1A.R.F. and G.P.R. contributed equally to this work.

  • ↵2To whom correspondence may be addressed. Email: glennm{at}ucsc.edu or jraskato{at}ucsc.edu.
  • Author contributions: A.R.F., G.P.R., T.S.F., R.S.L., G.L.M., and J.A.R. designed research; A.R.F., G.P.R., K.C., A.S., and K.Y. performed research; A.R.F., G.P.R., K.C., A.S., K.Y., R.S.L., G.L.M., and J.A.R. contributed new reagents/analytic tools; A.R.F., G.P.R., K.C., A.S., T.S.F., K.Y., R.S.L., G.L.M., and J.A.R. analyzed data; and A.R.F., G.P.R., G.L.M., and J.A.R. wrote the paper.

  • The authors declare no competing interest.

  • This article is a PNAS Direct Submission.

  • This article contains supporting information online at https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.2009238117/-/DCSupplemental.

Data Availability.

All study data are included in the paper and SI Appendix.

Published under the PNAS license.

View Full Text

References

  1. ↵
    1. R. J. O’Brien,
    2. P. C. Wong
    , Amyloid precursor protein processing and Alzheimer’s disease. Annu. Rev. Neurosci. 34, 185–204 (2011).
    OpenUrlCrossRefPubMed
  2. ↵
    1. C. Haass,
    2. D. J. Selkoe
    , Soluble protein oligomers in neurodegeneration: Lessons from the Alzheimer’s amyloid beta-peptide. Nat. Rev. Mol. Cell Biol. 8, 101–112 (2007).
    OpenUrlCrossRefPubMed
  3. ↵
    1. R. Kayed et al
    ., Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300, 486–489 (2003).
    OpenUrlAbstract/FREE Full Text
  4. ↵
    1. M. Ries,
    2. M. Sastre
    , Mechanisms of Aβ clearance and degradation by glial cells. Front. Aging Neurosci. 8, 160 (2016).
    OpenUrlCrossRefPubMed
  5. ↵
    1. G. K. Gouras et al
    ., Intraneuronal Abeta42 accumulation in human brain. Am. J. Pathol. 156, 15–20 (2000).
    OpenUrlCrossRefPubMed
  6. ↵
    1. F. M. LaFerla,
    2. K. N. Green,
    3. S. Oddo
    , Intracellular amyloid-beta in Alzheimer’s disease. Nat. Rev. Neurosci. 8, 499–509 (2007).
    OpenUrlCrossRefPubMed
  7. ↵
    1. S. Oddo et al
    ., Triple-transgenic model of Alzheimer’s disease with plaques and tangles: Intracellular Abeta and synaptic dysfunction. Neuron 39, 409–421 (2003).
    OpenUrlCrossRefPubMed
  8. ↵
    1. H. Du et al
    ., Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer’s disease. Nat. Med. 14, 1097–1105 (2008).
    OpenUrlCrossRefPubMed
  9. ↵
    1. T. T. Olsson,
    2. O. Klementieva,
    3. G. K. Gouras
    , Prion-like seeding and nucleation of intracellular amyloid-β. Neurobiol. Dis. 113, 1–10 (2018).
    OpenUrlCrossRef
  10. ↵
    1. X. Hu et al
    ., Amyloid seeds formed by cellular uptake, concentration, and aggregation of the amyloid-beta peptide. Proc. Natl. Acad. Sci. U.S.A. 106, 20324–20329 (2009).
    OpenUrlAbstract/FREE Full Text
  11. ↵
    1. R. P. Friedrich et al
    ., Mechanism of amyloid plaque formation suggests an intracellular basis of Abeta pathogenicity. Proc. Natl. Acad. Sci. U.S.A. 107, 1942–1947 (2010).
    OpenUrlAbstract/FREE Full Text
  12. ↵
    1. M. Serra-Batiste et al
    ., Aβ42 assembles into specific β-barrel pore-forming oligomers in membrane-mimicking environments. Proc. Natl. Acad. Sci. U.S.A. 113, 10866–10871 (2016).
    OpenUrlAbstract/FREE Full Text
  13. ↵
    1. E. Wesén,
    2. G. D. M. Jeffries,
    3. M. Matson Dzebo,
    4. E. K. Esbjörner
    , Endocytic uptake of monomeric amyloid-β peptides is clathrin- and dynamin-independent and results in selective accumulation of Aβ(1-42) compared to Aβ(1-40). Sci. Rep. 7, 2021 (2017).
    OpenUrl
  14. ↵
    1. H. H. Jarosz-Griffiths,
    2. E. Noble,
    3. J. V. Rushworth,
    4. N. M. Hooper
    , Amyloid-β receptors: The good, the bad, and the prion protein. J. Biol. Chem. 291, 3174–3183 (2016).
    OpenUrlAbstract/FREE Full Text
  15. ↵
    1. R. G. Nagele,
    2. M. R. D’Andrea,
    3. W. J. Anderson,
    4. H. Y. Wang
    , Intracellular accumulation of beta-amyloid(1-42) in neurons is facilitated by the alpha 7 nicotinic acetylcholine receptor in Alzheimer’s disease. Neuroscience 110, 199–211 (2002).
    OpenUrlCrossRefPubMed
  16. ↵
    1. J. V. Rushworth,
    2. H. H. Griffiths,
    3. N. T. Watt,
    4. N. M. Hooper
    , Prion protein-mediated toxicity of amyloid-β oligomers requires lipid rafts and the transmembrane LRP1. J. Biol. Chem. 288, 8935–8951 (2013).
    OpenUrlAbstract/FREE Full Text
  17. ↵
    1. C. V. Zerbinatti et al
    ., Apolipoprotein E and low density lipoprotein receptor-related protein facilitate intraneuronal Abeta42 accumulation in amyloid model mice. J. Biol. Chem. 281, 36180–36186 (2006).
    OpenUrlAbstract/FREE Full Text
  18. ↵
    1. R. Limbocker et al
    ., Trodusquemine enhances Aβ42 aggregation but suppresses its toxicity by displacing oligomers from cell membranes. Nat. Commun. 10, 225 (2019).
    OpenUrlCrossRefPubMed
  19. ↵
    1. Q. Cao et al
    ., Inhibiting amyloid-β cytotoxicity through its interaction with the cell surface receptor LilrB2 by structure-based design. Nat. Chem. 10, 1213–1221 (2018).
    OpenUrlCrossRefPubMed
  20. ↵
    1. P. P. Liu,
    2. Y. Xie,
    3. X. Y. Meng,
    4. J. S. Kang
    , History and progress of hypotheses and clinical trials for Alzheimer’s disease. Signal Transduct. Target. Ther. 4, 29 (2019).
    OpenUrl
  21. ↵
    1. L. Schneider
    , A resurrection of aducanumab for Alzheimer’s disease. Lancet Neurol. 19, 111–112 (2020).
    OpenUrlCrossRefPubMed
  22. ↵
    1. J. Laurén,
    2. D. A. Gimbel,
    3. H. B. Nygaard,
    4. J. W. Gilbert,
    5. S. M. Strittmatter
    , Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers. Nature 457, 1128–1132 (2009).
    OpenUrlCrossRefPubMed
  23. ↵
    1. D. A. Gimbel et al
    ., Memory impairment in transgenic Alzheimer mice requires cellular prion protein. J. Neurosci. 30, 6367–6374 (2010).
    OpenUrlAbstract/FREE Full Text
  24. ↵
    1. F. Dohler et al
    ., High molecular mass assemblies of amyloid-β oligomers bind prion protein in patients with Alzheimer’s disease. Brain 137, 873–886 (2014).
    OpenUrlCrossRefPubMed
  25. ↵
    1. L. T. Haas et al
    ., Metabotropic glutamate receptor 5 couples cellular prion protein to intracellular signalling in Alzheimer’s disease. Brain 139, 526–546 (2016).
    OpenUrlCrossRefPubMed
  26. ↵
    1. J. W. Um et al
    ., Metabotropic glutamate receptor 5 is a coreceptor for Alzheimer aβ oligomer bound to cellular prion protein. Neuron 79, 887–902 (2013).
    OpenUrlCrossRefPubMed
  27. ↵
    1. S. Dutta et al
    ., Suppression of oligomer formation and formation of non-toxic fibrils upon addition of mirror-image Aβ42 to the natural l-enantiomer. Angew. Chem. Int. Ed. Engl. 56, 11506–11510 (2017).
    OpenUrl
  28. ↵
    1. S. Dutta,
    2. T. S. Finn,
    3. A. J. Kuhn,
    4. B. Abrams,
    5. J. A. Raskatov
    , Chirality dependence of amyloid β cellular uptake and a new mechanistic perspective. ChemBioChem 20, 1023–1026 (2019).
    OpenUrl
  29. ↵
    1. Z. Y. Wang et al
    ., Knockdown of prion protein (PrP) by RNA interference weakens the protective activity of wild-type PrP against copper ion and antagonizes the cytotoxicity of fCJD-associated PrP mutants in cultured cells. Int. J. Mol. Med. 28, 413–421 (2011).
    OpenUrlPubMed
  30. ↵
    1. D. C. Bode,
    2. M. D. Baker,
    3. J. H. Viles
    , Ion channel formation by amyloid-β42 oligomers but not amyloid-β40 in cellular membranes. J. Biol. Chem. 292, 1404–1413 (2017).
    OpenUrlAbstract/FREE Full Text
  31. ↵
    1. M. A. Kostylev et al
    ., Liquid and hydrogel phases of PrP(C) linked to conformation shifts and triggered by Alzheimer’s amyloid-beta oligomers. Mol. Cell 72, 426–443.e12 (2018).
    OpenUrlCrossRefPubMed
  32. ↵
    1. D. Wade et al
    ., All-D amino acid-containing channel-forming antibiotic peptides. Proc. Natl. Acad. Sci. U.S.A. 87, 4761–4765 (1990).
    OpenUrlAbstract/FREE Full Text
  33. ↵
    1. S. T. Henriques,
    2. H. Peacock,
    3. A. H. Benfield,
    4. C. K. Wang,
    5. D. J. Craik
    , Is the mirror image a true reflection? Intrinsic membrane chirality modulates peptide binding. J. Am. Chem. Soc. 141, 20460–20469 (2019).
    OpenUrl
  34. ↵
    1. J. P. Colletier et al
    ., Molecular basis for amyloid-beta polymorphism. Proc. Natl. Acad. Sci. U.S.A. 108, 16938–16943 (2011).
    OpenUrlAbstract/FREE Full Text
  35. ↵
    1. M. F. Knauer,
    2. B. Soreghan,
    3. D. Burdick,
    4. J. Kosmoski,
    5. C. G. Glabe
    , Intracellular accumulation and resistance to degradation of the Alzheimer amyloid A4/beta protein. Proc. Natl. Acad. Sci. U.S.A. 89, 7437–7441 (1992).
    OpenUrlAbstract/FREE Full Text
  36. ↵
    1. I. R. Kleckner,
    2. M. P. Foster
    , An introduction to NMR-based approaches for measuring protein dynamics. Biochim. Biophys. Acta 1814, 942–968 (2011).
    OpenUrlCrossRefPubMed
  37. ↵
    1. N. D. Younan,
    2. K. F. Chen,
    3. R. S. Rose,
    4. D. C. Crowther,
    5. J. H. Viles
    , Prion protein stabilizes amyloid-β (Aβ) oligomers and enhances Aβ neurotoxicity in a Drosophila model of Alzheimer’s disease. J. Biol. Chem. 293, 13090–13099 (2018).
    OpenUrlAbstract/FREE Full Text
  38. ↵
    1. B. R. Fluharty et al
    ., An N-terminal fragment of the prion protein binds to amyloid-β oligomers and inhibits their neurotoxicity in vivo. J. Biol. Chem. 288, 7857–7866 (2013).
    OpenUrlAbstract/FREE Full Text
  39. ↵
    1. A. H. Brody,
    2. S. M. Strittmatter
    , Synaptotoxic signaling by amyloid beta oligomers in Alzheimer’s disease through prion protein and mGluR5. Adv. Pharmacol. 82, 293–323 (2018).
    OpenUrl
  40. ↵
    1. A. Aguzzi,
    2. C. Sigurdson,
    3. M. Heikenwaelder
    , Molecular mechanisms of prion pathogenesis. Annu. Rev. Pathol. 3, 11–40 (2008).
    OpenUrlCrossRefPubMed
  41. ↵
    1. P. Madhu,
    2. S. Mukhopadhyay
    , Preferential recruitment of conformationally distinct amyloid-β oligomers by the intrinsically disordered region of the human prion protein. ACS Chem. Neurosci. 11, 86–98 (2020).
    OpenUrl
  42. ↵
    1. D. B. Freir et al
    ., Interaction between prion protein and toxic amyloid β assemblies can be therapeutically targeted at multiple sites. Nat. Commun. 2, 336 (2011).
    OpenUrlCrossRefPubMed
  43. ↵
    1. C. Balducci et al
    ., Synthetic amyloid-beta oligomers impair long-term memory independently of cellular prion protein. Proc. Natl. Acad. Sci. U.S.A. 107, 2295–2300 (2010).
    OpenUrlAbstract/FREE Full Text
  44. ↵
    1. I. J. Whitehouse et al
    ., Ablation of prion protein in wild type human amyloid precursor protein (APP) transgenic mice does not alter the proteolysis of APP, levels of amyloid-β or pathologic phenotype. PLoS One 11, e0159119 (2016).
    OpenUrl
  45. ↵
    1. T. Kim et al
    ., Human LilrB2 is a β-amyloid receptor and its murine homolog PirB regulates synaptic plasticity in an Alzheimer’s model. Science 341, 1399–1404 (2013).
    OpenUrlAbstract/FREE Full Text
  46. ↵
    1. M. Cissé et al
    ., Ablation of cellular prion protein does not ameliorate abnormal neural network activity or cognitive dysfunction in the J20 line of human amyloid precursor protein transgenic mice. J. Neurosci. 31, 10427–10431 (2011).
    OpenUrlAbstract/FREE Full Text
  47. ↵
    1. X. D. Shi et al
    ., Blocking the interaction between EphB2 and ADDLs by a small peptide rescues impaired synaptic plasticity and memory deficits in a mouse model of Alzheimer’s disease. J. Neurosci. 36, 11959–11973 (2016).
    OpenUrlAbstract/FREE Full Text
  48. ↵
    1. E. Terzi,
    2. G. Hölzemann,
    3. J. Seelig
    , Interaction of Alzheimer beta-amyloid peptide(1-40) with lipid membranes. Biochemistry 36, 14845–14852 (1997).
    OpenUrlCrossRefPubMed
  49. ↵
    1. J. Habchi et al
    ., Cholesterol catalyses Aβ42 aggregation through a heterogeneous nucleation pathway in the presence of lipid membranes. Nat. Chem. 10, 673–683 (2018).
    OpenUrl
  50. ↵
    1. S. Jin et al
    ., Amyloid-β(1-42) aggregation initiates its cellular uptake and cytotoxicity. J. Biol. Chem. 291, 19590–19606 (2016).
    OpenUrlAbstract/FREE Full Text
  51. ↵
    1. R. Freer et al
    ., A protein homeostasis signature in healthy brains recapitulates tissue vulnerability to Alzheimer’s disease. Sci. Adv. 2, e1600947 (2016).
    OpenUrlFREE Full Text
  52. ↵
    1. R. Kundra,
    2. P. Ciryam,
    3. R. I. Morimoto,
    4. C. M. Dobson,
    5. M. Vendruscolo
    , Protein homeostasis of a metastable subproteome associated with Alzheimer’s disease. Proc. Natl. Acad. Sci. U.S.A. 114, E5703–E5711 (2017).
    OpenUrlAbstract/FREE Full Text
  53. ↵
    1. T. Fülöp,
    2. R. F. Itzhaki,
    3. B. J. Balin,
    4. J. Miklossy,
    5. A. E. Barron
    , Role of microbes in the development of Alzheimer’s disease: State of the art–An international symposium presented at the 2017 IAGG congress in San Francisco. Front. Genet. 9, 362 (2018).
    OpenUrl
  54. ↵
    1. T. Fülöp et al
    ., Targeting infectious agents as a therapeutic strategy in Alzheimer’s disease. CNS Drugs 34, 673–695 (2020).
    OpenUrl
  55. ↵
    1. G. Ill-Raga et al
    ., Activation of PKR causes amyloid ß-peptide accumulation via de-repression of BACE1 expression. PLoS One 6, e21456 (2011).
    OpenUrlPubMed
  56. ↵
    1. D. M. Cairns et al
    ., A 3D human brain-like tissue model of herpes-induced Alzheimer’s disease. Sci. Adv. 6, eaay8828 (2020).
    OpenUrlFREE Full Text
  57. ↵
    1. G. P. Roseman
    , “The central region of the cellular prion protein attenuates the intrinsic toxicity of N-terminus,” PhD thesis, University of California, Santa Cruz, CA (2019).
  58. ↵
    1. E. G. Evans,
    2. M. J. Pushie,
    3. K. A. Markham,
    4. H. W. Lee,
    5. G. L. Millhauser
    , Interaction between prion protein’s copper-bound octarepeat domain and a charged C-terminal pocket suggests a mechanism for N-terminal regulation. Structure 24, 1057–1067 (2016).
    OpenUrlCrossRefPubMed
  59. ↵
    1. A. R. Spevacek et al
    ., Zinc drives a tertiary fold in the prion protein with familial disease mutation sites at the interface. Structure 21, 236–246 (2013).
    OpenUrlCrossRefPubMed
  60. ↵
    1. F. Delaglio et al
    ., NMRPipe: A multidimensional spectral processing system based on UNIX pipes. J. Biomol. NMR 6, 277–293 (1995).
    OpenUrlCrossRefPubMed

Log in using your username and password

Forgot your user name or password?

Log in through your institution

You may be able to gain access using your login credentials for your institution. Contact your library if you do not have a username and password.
If your organization uses OpenAthens, you can log in using your OpenAthens username and password. To check if your institution is supported, please see this list. Contact your library for more details.

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.

Subscribers, for more details, please visit our Subscriptions FAQ.

Please click here to log into the PNAS submission website.

PreviousNext
Back to top
Article Alerts
Email Article

Thank you for your interest in spreading the word on PNAS.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Evidence for aggregation-independent, PrPC-mediated Aβ cellular internalization
(Your Name) has sent you a message from PNAS
(Your Name) thought you would like to see the PNAS web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Evidence for aggregation-independent, PrPC-mediated Aβ cellular internalization
Alejandro R. Foley, Graham P. Roseman, Ka Chan, Amanda Smart, Thomas S. Finn, Kevin Yang, R. Scott Lokey, Glenn L. Millhauser, Jevgenij A. Raskatov
Proceedings of the National Academy of Sciences Nov 2020, 117 (46) 28625-28631; DOI: 10.1073/pnas.2009238117

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Request Permissions
Share
Evidence for aggregation-independent, PrPC-mediated Aβ cellular internalization
Alejandro R. Foley, Graham P. Roseman, Ka Chan, Amanda Smart, Thomas S. Finn, Kevin Yang, R. Scott Lokey, Glenn L. Millhauser, Jevgenij A. Raskatov
Proceedings of the National Academy of Sciences Nov 2020, 117 (46) 28625-28631; DOI: 10.1073/pnas.2009238117
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Mendeley logo Mendeley
Proceedings of the National Academy of Sciences: 117 (46)
Table of Contents

Submit

Sign up for Article Alerts

Article Classifications

  • Physical Sciences
  • Chemistry
  • Biological Sciences
  • Biochemistry

Jump to section

  • Article
    • Abstract
    • Results
    • Discussion
    • Materials and Methods
    • Data Availability.
    • Acknowledgments
    • Footnotes
    • References
  • Figures & SI
  • Info & Metrics
  • PDF

You May Also be Interested in

Abstract depiction of a guitar and musical note
Science & Culture: At the nexus of music and medicine, some see disease treatments
Although the evidence is still limited, a growing body of research suggests music may have beneficial effects for diseases such as Parkinson’s.
Image credit: Shutterstock/agsandrew.
Scientist looking at an electronic tablet
Opinion: Standardizing gene product nomenclature—a call to action
Biomedical communities and journals need to standardize nomenclature of gene products to enhance accuracy in scientific and public communication.
Image credit: Shutterstock/greenbutterfly.
One red and one yellow modeled protein structures
Journal Club: Study reveals evolutionary origins of fold-switching protein
Shapeshifting designs could have wide-ranging pharmaceutical and biomedical applications in coming years.
Image credit: Acacia Dishman/Medical College of Wisconsin.
White and blue bird
Hazards of ozone pollution to birds
Amanda Rodewald, Ivan Rudik, and Catherine Kling talk about the hazards of ozone pollution to birds.
Listen
Past PodcastsSubscribe
Goats standing in a pin
Transplantation of sperm-producing stem cells
CRISPR-Cas9 gene editing can improve the effectiveness of spermatogonial stem cell transplantation in mice and livestock, a study finds.
Image credit: Jon M. Oatley.

Similar Articles

Site Logo
Powered by HighWire
  • Submit Manuscript
  • Twitter
  • Facebook
  • RSS Feeds
  • Email Alerts

Articles

  • Current Issue
  • Latest Articles
  • Archive

PNAS Portals

  • Anthropology
  • Chemistry
  • Classics
  • Front Matter
  • Physics
  • Sustainability Science
  • Teaching Resources

Information

  • Authors
  • Editorial Board
  • Reviewers
  • Librarians
  • Press
  • Site Map
  • PNAS Updates

Feedback    Privacy/Legal

Copyright © 2021 National Academy of Sciences. Online ISSN 1091-6490